[
  {
    "ts": "2026-02-11T01:31:00+00:00",
    "headline": "Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon.",
    "summary": "Could these two companies be biotech giants in the making?",
    "url": "https://www.fool.com/investing/2026/02/10/missed-out-on-eli-lilly-2-healthcare-stocks-with-b/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "443a253e-838d-3f59-b49f-eb855f1a4d69",
      "content": {
        "id": "443a253e-838d-3f59-b49f-eb855f1a4d69",
        "contentType": "STORY",
        "title": "Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon.",
        "description": "",
        "summary": "Could these two companies be biotech giants in the making?",
        "pubDate": "2026-02-11T01:31:00Z",
        "displayTime": "2026-02-11T01:31:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/311dc6a28d643b0bf2671d7d68071583",
          "originalWidth": 1400,
          "originalHeight": 934,
          "caption": "Person injecting a GLP-1 drug into their upper arm.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/IuM39n9wWtp1xvZdb6iZ8Q--~B/aD05MzQ7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/311dc6a28d643b0bf2671d7d68071583.cf.webp",
              "width": 1400,
              "height": 934,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/zEIN08ZuRqyC97nHHAd5Dg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/311dc6a28d643b0bf2671d7d68071583.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2026/02/10/missed-out-on-eli-lilly-2-healthcare-stocks-with-b/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/missed-eli-lilly-2-healthcare-013100642.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "INTC"
            },
            {
              "symbol": "VKTX"
            },
            {
              "symbol": "ABVX"
            },
            {
              "symbol": "NVDA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-11T04:34:49+00:00",
    "headline": "Eli Lilly Broadens Genetic Medicine Portfolio While Shares Screen As Undervalued",
    "summary": "Eli Lilly (NYSE:LLY) agreed to acquire Orna Therapeutics to expand its genetic medicine and in vivo cell therapy efforts, focused on engineered circular RNA and autoimmune disease targets. The company also entered a multi billion dollar collaboration with Innovent Biologics to co develop new oncology and immunology drugs for global markets. Both transactions are aimed at broadening Lilly's pipeline beyond its existing focus areas of obesity and diabetes. For you as an investor, these deals...",
    "url": "https://finance.yahoo.com/news/eli-lilly-broadens-genetic-medicine-043449819.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "029b90f7-5bbc-3b06-94ae-c2b07214953f",
      "content": {
        "id": "029b90f7-5bbc-3b06-94ae-c2b07214953f",
        "contentType": "STORY",
        "title": "Eli Lilly Broadens Genetic Medicine Portfolio While Shares Screen As Undervalued",
        "description": "",
        "summary": "Eli Lilly (NYSE:LLY) agreed to acquire Orna Therapeutics to expand its genetic medicine and in vivo cell therapy efforts, focused on engineered circular RNA and autoimmune disease targets. The company also entered a multi billion dollar collaboration with Innovent Biologics to co develop new oncology and immunology drugs for global markets. Both transactions are aimed at broadening Lilly's pipeline beyond its existing focus areas of obesity and diabetes. For you as an investor, these deals...",
        "pubDate": "2026-02-11T04:34:49Z",
        "displayTime": "2026-02-11T04:34:49Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/5eef176f2a2dc130a63fafe4bd1968dd",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/uZWvuDuy6_Wr6cKvxAFZcw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/5eef176f2a2dc130a63fafe4bd1968dd.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/g78F5NO5pySOmBHzFi6.eA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/5eef176f2a2dc130a63fafe4bd1968dd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-broadens-genetic-medicine-043449819.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-broadens-genetic-medicine-043449819.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "IVBIY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]